Indeed, clinical studies have shown that increased levels of haemoglobin and transferrin (both iron-bound molecules) are associated with hypertension [143] in humans, so the possibility for the translation of iron-depleting methods suggested by Joffin et al.[7] into a clinical setting for the treatment of hypertension is promising. The gene discussed is TF; the disease is Hypertension.